Explore captivating content and diverse perspectives on our Discover page. Uncover fresh ideas and engage in meaningful conversations
Natalizumab Market Gains Momentum as Demand for Advanced Multiple Sclerosis Therapies Continues to Rise
https://growthmarketreports.co....m/report/natalizumab
The global natalizumab market reached USD 2.19 billion in 2025, driven by rising autoimmune disease prevalence and biologic therapy advances.